The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Comparetive observation on Mirtazapine combined Sulpiride in the treatment of depression
Author(s): 
Pages: 58-59
Year: Issue:  7
Journal: CHINESE JOURNAL OF PRACTICAL NERVOUS DISEASES

Keyword:  米氮平舒必利抑郁症;
Abstract: 目的 探讨米氮平合用舒必利治疗抑郁症的疗效和不良反应.方法 对符合CCMD-3诊断标准中抑郁症的80例患者随机分为研究组(合用组40例)和对照组(单用米氮平组40例),治疗8周,采用汉米顿抑郁量表(HAMD)和不良反应量表(TESS)评定疗效和药物不良反应.结果 研究组疗效显著高于对照组,而不良反应和对照组相当.结论 米氮平合用小剂量舒必利治疗抑郁症的疗效优于单用米氮平,不良反应不增加,治疗依从性高.
Citations
Related Articles
loading...